All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells

• Published in: Journal of cell science Vol. 121; no. Pt 19; pp. 3207 - 3217
• Main Authors: Tao, Rong-Hua, Maruyama, Ichi N
• Format: Journal Article
• Language: English
• Published: England 01-10-2008
• Subjects: Animals; Cell Line, Tumor; Cell Nucleus - metabolism; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Endoplasmic Reticulum - metabolism; Fluorescence; Humans; Intracellular Space - metabolism; Ligands; Mice; Models, Biological; NIH 3T3 Cells; Protein Multimerization; Protein Structure, Tertiary; Protein Transport; Receptor, Epidermal Growth Factor - chemistry; Receptor, Epidermal Growth Factor - metabolism; Subcellular Fractions - metabolism
• DOI: 10.1242/jcs.033399
• EISSN: 1477-9137
• ISSN: 0021-9533

The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, also known as ErbB or HER, plays crucial roles in the development of multicellular organisms. Mutations and over-expression of the ErbB receptors have been implicated in a variety of human cancers. It is widely thought that the ErbB receptors are located in the plasma membrane, and that ligand binding to the monomeric form of the receptors induces its dimeric form for activation. However, it still remains controversial whether prior to ligand binding the receptors exist as monomers or dimers on the cell surface. Using bimolecular fluorescence complementation (BiFC) assays in the present study, we demonstrate that in the absence of bound ligand, all the ErbB family members have preformed, yet inactive, homo- and heterodimers on the cell surface, except for ErbB3 homodimers and heterodimers with cleavable ErbB4, which exist primarily in the nucleus. BiFC assays of the dimerization have also suggested that the ligand-independent dimerization of the ErbB receptors occurs in the endoplasmic reticulum (ER) before newly synthesized receptor molecules reach the cell surface. Based on BiFC and mammalian two-hybrid assays, it is apparent that the intracellular domains of the receptors are responsible for the spontaneous dimer formation. These provide new insights into an understanding of transmembrane signal transduction mediated by the ErbB family members, and are relevant to the development of anti-cancer drugs.